TEVA Q4 PROFIT UP 9 PCT, SEES GOOD 2006

Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA -- news) posted a 9 percent rise in fourth-quarter profit on Tuesday, helped by further strong sales of multiple sclerosis treatment Copaxone as it prepares launches of generic drugs in 2006. The Israeli company, one of the world's largest generic drugmakers, had record sales and profits in 2005.

Herald News Daily (http://www.heraldnewsdaily.com/stories/news-00150353.html)